2m 2m 2m 2m 2m 2m 2m
IMMUNOCORE SP ADS (IMCR)
NASDAQ
$29.85+$0.50 (+1.70%)
Price as of Jun 23, 2026 7:21 PM EDT- $1.5BMarket Cap
- -5.69%1-Year Change
- BiotechnologyIndustry
IMMUNOCORE SP ADS (IMCR)
$29.85+$0.50 (+1.70%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 400.0M +28.95% | 310.2M +24.37% | 249.4M +73.53% | 143.7M +441.99% | |
Cost of Revenue | 5.1M +86.27% | 2.7M +163.36% | 1.0M +128.41% | 454,000 N/A | |
Gross Profit | 394.9M +28.44% | 307.5M +23.79% | 248.4M +73.36% | 143.3M +440.28% | |
Sales and Marketing Expense | 165.4M +6.18% | 155.8M +7.81% | 144.5M +54.17% | 93.7M N/A | |
Research and Development Expense | -274.9M +23.73% | -222.2M +35.83% | -163.5M +83.41% | -89.2M +21.77% | |
Depreciation and Amortization Expense | 3.3M -22.31% | 4.2M +2.79% | 4.1M N/A | N/A N/A | |
Total Operating Expenses | 165.4M +6.18% | 155.8M +7.81% | 144.5M +54.17% | 93.7M N/A | |
Operating Profit | -45.4M -35.63% | -70.5M +18.13% | -59.6M +50.60% | -39.6M -70.70% | |
Interest Income | 16.5M -35.69% | 25.6M +42.43% | 18.0M N/A | N/A N/A | |
Interest Expense | -12.2M -35.44% | -18.8M +265.62% | -5.2M N/A | N/A N/A | |
Interest Income and Expense and Net | 4.3M -36.37% | 6.8M -47.21% | 12.8M N/A | 0 +100.00% | |
Total Nonoperating Income and Expense | 19.7M +38.95% | 14.2M +1,682.83% | -897,000 N/A | N/A N/A | |
Income before Taxes | -19.1M -63.92% | -52.9M -13.06% | -60.9M +47.71% | -41.2M -68.66% | |
Income Taxes | 16.4M +987.24% | -1.9M -66.98% | -5.6M +91.82% | -2.9M -68.94% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -35.5M -30.48% | -51.1M -7.60% | -55.3M +34.11% | -41.2M -68.66% | |
Net Income from Continuing Operations Applicable to Common | -19.1M -63.92% | -52.9M -13.06% | -60.9M +47.71% | -41.2M -68.66% | |
Basic EPS and Net Income | -0.71 -30.39% | -1.02 -9.73% | -1.13 +25.56% | -0.90 -70.97% | |
Diluted EPS and Net Income | -0.71 -30.39% | -1.02 -9.73% | -1.13 +25.56% | -0.90 -70.97% | |
Basic Weighted Average Shares | 50.3M +0.71% | 50.0M +2.25% | 48.9M +6.94% | 45.7M +7.59% | |
Diluted Weighted Average Shares | 50.3M +0.71% | 50.0M +2.25% | 48.9M +6.94% | 45.7M +7.59% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 467.7M +2.63% | 455.7M +2.96% | 442.6M +33.10% | 332.5M +39.79% | |
Short-Term Investments | 396.4M +8.72% | 364.6M N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 864.2M +5.34% | 820.4M +85.34% | 442.6M +33.10% | 332.5M +39.79% | |
Total Current Assets | 996.7M +7.19% | 929.9M +75.84% | 528.8M +34.94% | 391.9M +49.16% | |
Accumulated Depreciation | 60.8M +9.91% | 55.3M +5.76% | 52.3M N/A | N/A N/A | |
Property and Plant and Equipment and Net | 11.5M +13.58% | 10.1M +9.52% | 9.2M +42.38% | 6.5M -27.64% | |
Total Long-Term Assets | 20.3M +18.49% | 17.1M +18.27% | 14.5M -66.83% | 43.6M +11.76% | |
Total Assets | 1.1B +5.72% | 1.0B +69.10% | 597.0M +37.08% | 435.5M +44.32% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 246.7M +16.27% | 212.2M +52.63% | 139.0M +67.31% | 83.1M +35.81% | |
Total Long-Term Debt | 393.1M +0.54% | 391.0M +714.42% | 48.0M N/A | N/A N/A | |
Total Long-Term Liabilities | 46.4M +1.79% | 45.6M +13.57% | 40.1M -45.50% | 73.7M +6.70% | |
Total Liabilities | 686.2M +5.77% | 648.8M +184.36% | 228.2M +45.54% | 156.8M +20.38% | |
Retained Earnings | -831.3M +4.46% | -795.8M +6.86% | -744.7M +185.04% | -261.3M -45.73% | |
Total Stockholders Equity | 381.0M +5.63% | 360.7M -2.20% | 368.8M +32.32% | 278.8M +62.50% | |
Total Shares Outstanding | 50.7M +1.25% | 50.1M +0.68% | 49.7M N/A | 0 -100.00% | |
Cash Flow | |||||
Cash from Operating Activities | -10.7M -141.10% | 26.1M +786.43% | 2.9M +111.36% | -25.9M -73.06% | |
Capital Expenditures | 4.3M -16.10% | 5.2M -4.65% | 5.4M N/A | N/A N/A | |
Cash from Investing Activities | -16.3M -95.40% | -355.1M +6,446.16% | -5.4M -2,910.88% | 193,000 +152.59% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 12.4M -96.40% | 343.9M +901.23% | 34.3M -69.99% | 114.5M -44.07% | |
Financials Ratio | |||||
Gross Margin | 98.73% -0.39% | 99.12% -0.47% | 99.58% -0.10% | 99.68% N/A | |
Operating Margin | -11.34% -50.09% | -22.71% -5.02% | -23.91% -13.21% | -27.56% -94.59% | |
Return on Assets | -3.42% -46.22% | -6.36% -40.61% | -10.71% -4.23% | -11.18% -78.79% | |
Return on Equity | -9.58% -31.63% | -14.00% -17.98% | -17.07% -6.74% | -18.31% -84.21% | |
Revenue Growth | 28.95% +18.83% | 24.37% -66.86% | 73.53% -83.36% | 441.99% +3,803.47% | |
Current Ratio | 4.04 -7.81% | 4.38 +15.21% | 3.80 -19.35% | 4.72 +9.83% | |
Cash Ratio | 1.90 -11.73% | 2.15 -32.54% | 3.18 -20.45% | 4.00 +2.93% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow